Reflect Scientific, Inc.
RSCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $4 | $4 |
| - Cash | $2 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $4 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 42.8% | -24% | 7.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 57.3% | 64.4% | 38.6% | 16.9% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 12.7% | -5.6% | 20.4% | 0.3% |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 10.3% | -2.1% | 15.2% | -5.2% |
| EPS Diluted | 0.001 | -0 | 0.001 | -0 |
| % Growth | 600% | -114.3% | 450% | – |
| Operating Cash Flow | – | – | $0 | – |
| Capital Expenditures | – | – | $0 | – |
| Free Cash Flow | – | – | $0 | – |